CLY

CLINDAMYCIN

Find entries where: CLY

is present as a standalone ligand in 5 entries

Find related ligands:

Chemical Component Summary
Name	CLINDAMYCIN
Identifiers	(1R,2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-oxan-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide
Formula	C₁₈ H₃₃ Cl N₂ O₅ S
Molecular Weight	424.983
Type	NON-POLYMER
Isomeric SMILES	CCC[C@@H]1C[C@H]([N@@](C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl
InChI	InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1
InChIKey	KDLRVYVGXIQJDK-AWPVFWJPSA-N

Chemical Details
Formal Charge	0
Atom Count	60
Chiral Atom Count	9
Bond Count	61
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB01190
Name	Clindamycin
Groups	vet_approved approved
Description	Clindamycin is a semi-synthetic lincosamide antibiotic used in the treatment of a variety of serious infections due to susceptible microorganisms[L11599,L11596] as well as topically for acne vulgaris.[L11593] It has a relatively narrow spectrum of activity that includes anaerobic bacteria as well as gram-positive cocci and bacilli and gram-negative bacilli.[A190621] Interestingly, clindamycin appears to carry some activity against protozoans, and has been used off-label in the treatment of toxoplasmosis, malaria, and babesiosis.[A190657] Clindamycin is derived from, and has largely replaced, [lincomycin], a naturally occurring lincosamide and the eponymous member of this antibiotic class, due to its improved properties over the parent compound. The name lincomycin is derived from Lincoln, Nebraska, where it was first isolated from _Streptomyces lincolnensis_ found in a soil sample.[A190621]
Synonyms	Clindamycin palmitate hydrochloride 7-CDL Clindamicina Clindamycinum Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside Clindamycin 7(S)-Chloro-7-deoxylincomycin Clindamycin phosphate Clindamycine Clindamycin hydrochloride
Brand Names	Dalacin C Flavoured Granules Clindamycin Injection, USP Clindamycin Phosphate and Benzoyl Peroxide Ratio-clindamycin Capsules-150mg Clindamycin 1% / Niacinamide 2% / Tazarotene 0.05% Clindamycin Dalacin Vaginal Cream Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% Nra-clindamycin Clindamycin HCL Clindavix Clindamycin 1% / Niacinamide 4% Clindamycin Phosphate and Tretinion Benzoyl Peroxide 2.5%, Clindamycin Phosphate 1%, Niacinamide 2% / Tretinoin 0.05% Dalacin C 300 mg Clindamycin 1% / Niacinamide 4% / Tretinoin 0.025% Riva-clindamycin Taro-benzoyl Peroxide / Clindamycin Kit Clindamycin in 5 Percent Dextrose CLIN-Single Use Kit Clindamycin Phosphate Topical Solution USP Ratio-clindamycin Capsules - 300mg Ag-clindamycin Evoclin Veltin Benzaclin Cleocin Hydrochloride Clindasol Cleocin Pediatric Nu-clindamycin Clindamycin Injection In 5% Dextrose ClindaReach Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.1% Clindamycin Injection Sdz NuCaraRXPAK Clindamycin hydrochloride Cleocin T Clindamycin and Benzoyl Peroxide Jamp Clindamycin Clindamycine-150 Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.05% Clindacin PAC Neuac Truemed Group LLC Clindamycin 1% / Niacinamide 4% / Tretinoin 0.05% Neuac Kit Teva-clindamycin Clindamycin Palmitate Hydrochloride (Pediatric) Ziana Clindamycin IV Infusion Dalacin T 1% Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.025% Clindamycine-300 Cleocin Phosphate Clindamycin Phosphate and Benzoyl Peroxide Clindamycin Phosphate and Benzoyl Peroxide Cabtreo Ava-clindamycin Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 4% Clindamax Clindamycin Phoaphate Topical Solution, 1% Acanya Clindamycin phosphate and benzoyl peroxide Dalacin C Phosphate Clindacin P Biacna Topical Gel Taro-clindamycin Clindap-T Clindacin Med-clindamycin Cleocin Clindamycin Hydrochloride Clindamycin 1% / Hydrocortisone 2.5% / Niacinamide 4% PMS-clindamycin Clinda-Derm Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.025% Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.05% Clindamycin Phosphate Topical Solution USP, 1% Taro-clindamycin/benzoyl Peroxide Gel Auro-clindamycin Clindamycin Phosphate and Tretinoin NuCaraClinPAK Clindamycin Phosphate Clindamycin - Benzoyl Peroxide Clindagel Clindamycin 1% / Sodium Sulfacetamide Monohydrate 5% / Tretinoin 0.025% Xaciato Clindesse Adapalene 0.1% / Benzoyl Peroxide 2.5% / Clindamycin 1% Apo-clindamycin Clindamycin 1% / Niacinamide 4% / Spironolactone 2% / Tretinoin 0.025% Clindamycin Phosphate 1.2% and Tretinoin 0.025% ClindaMax Clindoxyl Adv Gel Clindamycin Palmitate Hydrochloride Cleocin Phosphate (0009-6582) (standalone) Clinda-T Clindets CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05% Adapalene 0.3% / Benzoyl Peroxide 2.5% / Clindamycin 1% Clindamycin Phosphate Injection USP Liq CLIN-LIDO-Single Use Kit Onexton Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 4% Clindamycin Phoaphate Topical USP, 1% Benzoyl Peroxide 5% / Clindamycin1% / Niacinamide 2% / Tretinoin 0.025% Clindacin ETZ Clindoxyl Gel Mylan-clindamycin Dalacin C 150 mg Priva-clindamycin Clindamycin Phoaphate Topical Solution USP, 1% M-clindamycin Clindamycin Injection USP Clindamycin Palmitate Hydrochloride (pediatric) Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025% Clindamycin phosphate Duac
Indication	In oral and parenteral formulations, clindamycin is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria, as well as susceptible staphylococci, streptococci, and pneumococci.[L11599,L11602] Used topically, it is indicated for the treatment of acne vulgaris[L11593,L11611,L11605] and is available in combination with [benzoyl peroxide][L11584] or [tretinoin][L11590] for this purpose, or as a triple combination therapy with benzoyl peroxide and [adapalene].[L48666] Clindamycin is also indicated as a vaginal cream[L11596], suppository[L11608], or gel[L39416] for the treatment of bacterial vaginosis in non-pregnant females. Clindamycin is used for antimicrobial prophylaxis against _Viridans_ group streptococcal infections in susceptible patients undergoing oral, dental, or upper respiratory surgery, and may be used for prophylaxis against bacterial endocarditis in penicillin-allergic patients at high risk of these infections.[L11629]
Categories	Agents that produce neuromuscular block (indirect) Anti-Acne Preparations Anti-Acne Preparations for Topical Use Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antibiotics for Pneumocystis Pneumonia Antiinfectives for Systemic Use Antiinfectives for Treatment of Acne Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (moderate) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Decreased Sebaceous Gland Activity Dermatologicals Enzyme Inhibitors Genito Urinary System and Sex Hormones Glycosides Gynecological Antiinfectives and Antiseptics Lincomycins Lincosamide Antibacterial Lincosamides Macrolides Macrolides, Lincosamides and Streptogramins Neuromuscular Blockade Neurotoxic agents P-glycoprotein substrates Protein Synthesis Inhibitors Pyrrolidines
ATC-Code	D10AF01 J01FF01 D10AF51 G01AA10
CAS number	18323-44-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
50S ribosomal protein L1	MAKKGKKYQEAASKVDRTQHYSVEEAIKLAKETSIANFDASVEVAFRLGI...	unknown	inhibitor
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate,inhibitor
Alpha-1-acid glycoprotein 1	MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAF...	unknown	substrate
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682